Editorial Comment
Editorial comment to “The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study”
-
The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study
- Juria Nakano,
- Fumihiko Urabe,
- Yuria Kiuchi,
- Shigeyoshi Takamizawa,
- Hirotaka Suzuki,
- Shota Kawano,
- Keiichiro Miyajima,
- Wataru Fukuokaya,
- Kazuhiro Takahashi,
- Kosuke Iwatani,
- Yu Imai,
- Sotaro Kayano,
- Koichi Aikawa,
- Takafumi Yanagisawa,
- Kojiro Tashiro,
- Steffi Yuen,
- Shun Sato,
- Shunsuke Tsuzuki,
- Jun Miki,
- Takahiro Kimura,
- JIKEI-YAYOI Collaborative Group,
- Volume 31Issue 4International Journal of Urology
- pages: 394-401
- First Published online: December 27, 2023
Nozomi Hayakawa M.D., Ph.D.,
Nozomi Hayakawa M.D., Ph.D.
Department of Urology, St. Marianna University School of Medicine, Kawasaki, Japan
Search for more papers by this author Eiji Kikuchi M.D., Ph.D.,
Corresponding Author
Eiji Kikuchi M.D., Ph.D.
Department of Urology, St. Marianna University School of Medicine, Kawasaki, Japan
Eiji Kikuchi M.D., Ph.D., Department of Urology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Email: [email protected]
Search for more papers by this author
Nozomi Hayakawa M.D., Ph.D.,
Nozomi Hayakawa M.D., Ph.D.
Department of Urology, St. Marianna University School of Medicine, Kawasaki, Japan
Search for more papers by this author Eiji Kikuchi M.D., Ph.D.,
Corresponding Author
Eiji Kikuchi M.D., Ph.D.
Department of Urology, St. Marianna University School of Medicine, Kawasaki, Japan
Eiji Kikuchi M.D., Ph.D., Department of Urology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Email: [email protected]
Search for more papers by this author
First published: 29 January 2024
No abstract is available for this article.
CONFLICT OF INTEREST STATEMENT
Eiji Kikuchi received honoraria for lectures from MSD K.K. and Astellas Pharma Inc. Nozomi Hayakawa has no conflicts of interest to declare.
REFERENCES
- 1Mori K, Hatakeyama S, Enokida H, Miyake H, Kikuchi E, Nishiyama H, et al. Summary of the clinical practice guidelines for upper tract urothelial carcinoma 2023 by the Japanese Urological Association. Int J Urol. 2024; 31: 194–207.
- 2Rouprêt M, Gontero P, Birtle A, et al. EAU guidelines on upper tract urothelial carcinoma. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Upper-Urinary-Tract-Urothelial-Carcinoma-2023.pdf
- 3Coleman JA, Clark PE, Bixler BR, Buckley DI, Chang SS, Chou R, et al. Diagnosis and Management of non-metastatic upper tract urothelial carcinoma: AUA/SUO guideline. J Urol. 2023; 209: 1071–1081.
- 4Nakano J, Urabe F, Kiuchi Y, et al. The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study. Int J Urol. 2024; 31: 394–403.
- 5Fukuhara H, Kurabayashi A, Furihata M, Setuda S, Takahashi K, Murakami K, et al. 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence ureterorenoscopy for urinary upper tract urothelial carcinoma -preliminary prospective single centre trial. Photodiagn Photodyn Ther. 2020; 29:101617.
